Simons Foundation: Genomics of ASD: Pathways to Genetic Therapies (SFARI)

Aim: understanding of the genetic basis of autism spectrum disorder (ASD), the molecular and cellular consequences of genetic risk, and will provide a foundation for the development of treatments of genetically defined forms of the condition. The RFA comprises distinct focus areas on (1) systems biology of ASD risk genes to identify points of biological convergence, (2) functional analysis of ASD-associated variants, and (3) development of gene-based therapies. Special emphasis is placed on the use of scalable methods, especially as applied to genes that are suitable therapeutic targets.
Maximum Budget- Explorer Track $400,000 over a period of up to two (2) years.

Expansion Track $1,500,000 over a period of up to three (3) years.

Collaboration Track $750,000 per lab over a period of up to three (3) years.

Please contact the research authority before submitting – Nonprofit.

https://www.sfari.org/grant/genomics-of-asd-pathways-to-genetic-therapies-request-for-applications?mc_cid=618a9fc7a3&mc_eid=9acb259ced